[1]
Crema, J.C. et al. 2026. USE OF DAPAGLIFLOZIN (FORXIGA) IN THE TREATMENT OF HEART FAILURE: CURRENT EVIDENCE AND CLINICAL EFFICACY. Seven Editora. (May 2026), 711–721. DOI:https://doi.org/10.56238/sevened2026.020-043.